3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 31.50
-0.40 (-1.25%)
Apr 20, 2026, 9:45 AM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.48 billion as of April 17, 2026. Its market cap has decreased by -50.77% in one year.
Market Cap
2.48B
Enterprise Value
2.05B
Revenue
206.74M
Ranking
n/a
PE Ratio
37.98
Stock Price
31.50
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has decreased from 2.74B to 2.48B, a decrease of -9.25%. That is a compound annual growth rate of -1.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.48B | -33.95% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.93B |
| Syngen Biotech | 2.89B |
| HeXun Biosciences | 2.77B |
| Sunhawk Vision Biotech | 2.73B |
| GlycoNex Incorporation | 2.61B |
| G&E Herbal Biotechnology | 2.39B |
| TWi Biotechnology | 2.38B |
| Chunghwa Chemical Synthesis & Biotech | 2.28B |